The oncogene collagen triple helix repeat containing‐1 promotes the advancement of HBV‐related HCC by activating hypoxia‐inducible factor 1 alpha and vascular endothelial growth factor via the PI3K/Akt/mTOR pathway.49 The gene discussed is MTOR; the disease is hepatocellular carcinoma.